JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Radiology Section DOI : 10.7860/JCDR/2015/10850.5378
Year : 2015 | Month : Jan | Volume : 9 | Issue : 1 Full Version Page : TC01 - TC07

Clinico-Radiological Correlation in a Cohort of Cervical Myelopathy Patients

Praveen S. Kumar1, R.Y. Kalpana2

1 Associate Professor, Department of Neurology, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India.
2 Junior Consultant, Department of Pediatrics, Sagar Hospitals, Bangalore, Karnataka, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Praveen Kumar S, Associate Professor, Department of Neurology, Bowring & Lady Curzon Hospitals, Bangalore Medical College & Research Institute, Bangalore-560001, Karnataka, India.
E-mail: dmpraveen@gmail.com
Abstract

Objective: Though both clinical evaluation and MRI are complimentary in detection and precise localization of the level of lesion in patients with cervical myelopathy, there is paucity of data comparing segment specific clinical features with the MRI abnormalities in cervical myelopathy.

Materials and Methods: Thirty one patients with cervical myelopathy and abnormal MRI of the cervical spine (signal changes in the cord) admitted to the neurology and neurosurgery wards during the study period were included in the study. The patients were prospectively evaluated by a detailed neurological examination. Clinically, the site of lesion was determined by highest of the pyramidal, sensory or segmental features of involvement. The MRI lesions were categorized based on the vertebral level at which the abnormalities were seen. The patients were divided into three groups according to the site of lesion on MRI: (1) cervico-medullary (foramen magnum to C1) lesions (2) upper cervical (C2-C4) lesions and (3) lower cervical (C5-T1) lesions. Comparisons of clinical symptoms, signs and level of lesion with MRI abnormalities were done and the level of significance was set at p < 0.05.

Results: Clinical evaluation showed limb weakness in all, sensory loss in 90%, sphincter disturbances in 67.7%, scissoring gait in 32.2%, diaphragmatic weakness in 12.9% of patients. Based on clinical examination the site of lesion was cervico-medullary in 9, upper cervical region in 4 and lower cervical region of involvement in five patients. The maximal antero-posterior extent of the lesion and neurological deficits were concordant (p-0.05). As compared to pyramidal signs or sensory abnormalities, segmental features – segmental sensory loss, weakness, wasting or ‘reflex’ loss – were most concordant with the MRI level of lesion (p - 0.03). Among ‘motor’, ‘sensory’ and ‘reflex’ levels, the ‘reflex (DTR)’ levels were most concordant with the MRI level of lesion (p – 0.04).

Conclusion: Segmental features form the foundation for clinical localization of the level of lesion. Though the clinical level of lesion and MRI level of lesion were discordant in 14 patients, clinical evaluation may still provide useful information.

Keywords

Introduction

Cervical myelopathy is a commonly encountered entity in neurological practice and the diagnosis of level of lesion is not always straight forward. It is caused by various etiologies like cervical spondylotic myelopathy (CSM), syrinx, multiple sclerosis, intramedullary tumors and trauma. In patients with cervical myelopathy, the presence of characteristic symptoms in the form neck pain, L’hermitte’s sign, weakness and wasting in upper limbs etc would help to localize the lesion to cervical cord. Similarly clinical signs such as loss of reflexes, dissociated sensory loss in upper limbs, respiratory failure etc. would help to make segmental localization to cervical cord [1,2]. The clinical impression can be confirmed or negated using MRI of the cervical spine [3]. The latter has especially made diagnosis of cervical cord lesions easier as it depicts intramedullary lesions much better. However, as with other investigatory procedures, MRI also has limitations. Thus, MRI could be normal in the presence of unequivocal evidence of cervical cord lesion [4,5]. Further, when incidental lesions like spondylotic changes in the elderly or multiple lesions/pathologies are present, precise localization of the lesion responsible for patients symptoms becomes difficult [69].

Though both clinical evaluation and MRI are complimentary in detection and precise localization of the level of lesion in patients with cervical myelopathy, there is paucity of data comparing segment specific clinical features with the MRI abnormalities in cervical myelopathy which is essential for pre-operative evaluation as well as for intra-operative monitoring. The present study was undertaken to study and correlate the clinical features and MRI abnormalities of cervical myelopathies.

Materials and Methods

This was a prospective study carried out at the Department of Neurology at a teaching hospital in Bangalore over a period of one year. Ethical clearance for the study was obtained from the institution Ethics Committee. Before recruitment into the study, informed consent was obtained from all the subjects of the study.

Non-consecutive patients with cervical myelopathy and abnormal MRI of the cervical spine (signal changes in the cord) admitted to the neurology and neurosurgery wards during the study period were included in the study. The exclusion criteria were – a) clinical or MRI evidence of involvement of neuraxis other than cervical cord b) patients with peripheral neuropathy detected during clinical examination and confirmed by nerve conduction studies

The patients were prospectively evaluated by a detailed neurological examination. Clinically, the site of lesion was determined by highest of the pyramidal, sensory or segmental features of involvement. The features that were made use of for determining level of lesion cord included in [Table/Fig-1]. When a combination of the findings mentioned in [Table/Fig-1] were present, the vertical extent of the lesion was ascribed to the highest and lowest level of lesion that was necessary to explain the neurological deficits.

The clinical features that were made use of for determining level of cord lesion

Downbeat Nystagmus – cervico-medullary region

Onion-peel sensory loss over face – C1-C2 level

Sensory loss over occipital region – C2 level

Weakness of Sternomastoid/ Trapezius – C2/3 level

Sensory loss over neck area – C3-C4 level

Diaphragmatic weakness – C4 level

Radicular (non-pyramidal) distribution of weakness – segment affected

Loss of tendon jerk – segmental level of the reflex

Segmental distribution of wasting – segment affected

Sensory level – 1 segment above the sensory level

Suspended sensory loss – 1 to 2 segments above the upper margin of suspended sensory loss

Loss of vibration sense over spine – level affected

Severe impairment of position sense in upper limbs in a patient with myelopathy – Cervical cord

Pyramidal signs (brisk reflexes in all 4 limbs with extensor plantar response on one or both sides with or without spasticity and pyramidal type of weakness) in the presence of normal jaw jerk – cervical cord above C5. If the trapezius reflex was also brisk, the lesion was localized to above C2.

Lhermitte’s sign – cervical cord

Horner’s syndrome – cervical cord


All patients had been investigated with MRI of the cervical cord. Axial T1 and T2 weighted spin-echo sequences were performed at the level of lesion. Post-contrast (Gadolinium) images of the cervical cord were done in all patients. MRI brain (post contrast and FLAIR sequences) were done when felt necessary. MRI was interpreted by radiologist who was blinded to the clinical data. Lesions were defined as areas of unequivocally increased signal on T2-weighted sequences or of decreased signal on T1-weighted sequences. Abnormalities were accepted only when identified on both sagittal and axial images.

The MRI lesions were categorized based on the vertebral level at which the abnormalities were seen. The patients were divided into three groups according to the site of lesion on MRI: (1) cervico-medullary (foramen magnum to C1) lesions (2) upper cervical (C2-C4) lesions and (3) lower cervical (C5-T1) lesions.

Statistical Analysis

SPSS (ver10) software was used for statistical analysis. Data were expressed using descriptive statistics, such as mean and standard deviation (SD) for continuous variables and frequency, percentages for categorical variables. Comparisons of clinical symptoms, signs and level of lesion with MRI abnormalities were done by using Independent sample t-test. Data were considered significant for p-values less than 0.05 (p<0.05).

Results

During the study period, 40 patients with cervical myelopathy were seen. However, those meeting the study criteria among these were 31 patients who formed the subjects of this study. M:F was 22:9. The mean age was 38.5 ± 15.2 (Range: 26–68 years). These 31 patients recruited into the study had cervical myelopathy due to various neurological and neurosurgical disorders. The mean duration of illness at the time of recruitment into study was 272.45 ± 317.7 d (range 45-1080 d). The symptoms were non-progressive in 15, progressive in 12, and relapsing – remitting type in four patients.

Clinical Features

The patients presented with various combinations of motor, sensory and sphincter symptoms. The first symptoms were neck pain in 13 (41.9%), upper limb weakness in 6 (19.3%), lower limb weakness in 5 (16.1%), upper limb pain & paresthesias in 4 (12.9%) and gait disturbance in 3 patients (9.6%). With evolution and/or progression of the illnesses, existing symptoms worsened and new symptoms made their appearance.

Limb weakness was the commonest symptom reported by 29 patients and affected the lower limbs most often. Sphincter disturbance was the second commonest symptom (n=21). Fifteen patients complained of difficulty in walking. Neck pain was found in 13 patients. L’hermitte’s phenomenon was present in 12 patients. 17 patients complained of pain and/or paresthesias, the distribution being radicular in 3, facial in 3, distal extremities in 4 and below a sensory level in 7 patients.

A detailed neurological examination was carried out in all patients. The various neurological signs in our patients are given in [Table/Fig-2]. Tendon jerks (DTRs) were brisk in lower limbs in 29 patients and in upper limbs in 28 patients. Sluggish to absent tendon jerks in upper limbs were found in 8 patients. The details are as follows: absent bilateral biceps and supinator jerk – 3/8; absent bilateral triceps jerk – 1/8; absent biceps jerk only – bilateral in1/8 and unilateral in 3/8 (right side - one; left side - two).

Neurological signs (n=31)

SIGNSNumber (#) (%)
Nystagmus4 (12.9)
Horner’s syndrome3 (9.6)
Motor deficits (n=31)
Wasting of extensor muscles of neck11 (35.4)
Trapezius muscle involvement5 (16.1)
Sternocleidomastoid muscle weakness2 (6.4)
Diaphragmatic weakness4 (12.9)
Upper extremities
Spasticity18 (58.0)
Wasting of small muscles of hand1 (9.6)
Exaggerated DTRs24 (77.4)
Hypoactive or absent DTRs18 (58.0)
Lower extremities
Spasticity22 (58.0)
Exaggerated DTRs29 (93.5)
Babinski sign31 (100)
Modality / Pattern of sensory loss (n=28)
Loss of Joint position sense23 (82.1)
Loss of vibration sense over spine21 (75.0)
Pan-sensory loss below a ‘level’9 (29.0)
Dissociated Sensory loss5 (16.1)
‘Onion peel’ sensory loss over face5 (16.1)
Brown-Sequard type of loss1 (3.5)

Examination showed limb weakness in all the 31 patients. Details of the distribution of weakness are given in [Table/Fig-3]. Examination of sensory system showed abnormalities in most of the patients. However, in three patients, there was no evidence of sensory loss. Sensory deficits in the remaining 28 patients are given in [Table/Fig-2].

Distribution of weakness: (n=31)

Distribution of WeaknessNumber of patients (#) (%)
Quadriparesis – symmetric6 (19.3)
Quadriparesis – asymmetric
(right > left)2 (6.4)
(left > right)2 (6.4)
Paraparesis + Segmental weakness in upper limbs3 (9.6)
Triparesis (bilateral lower limb & one upper limb weakness)2 (6.4)
Paraparesis – symmetric5 (16.1)
Paraparesis- asymmetric
(right > left)2 (6.4)
(left > right)2 (6.4)
Hemiparesis (sparing face)
leg > arm: Right side2 (6.4)
leg > arm: Left side1 (3.2)
Hemiparesis (sparing face)
arm > leg: Right side1 (3.2)
arm> leg: Left side1 (3.2)
Bilateral upper limb weakness2 (6.4)

The site of lesion (upper extent) was determined by the highest of the pyramidal, sensory or segmental involvement. The details of the various neurological deficits suggesting level of lesion are given in [Table/Fig-4].

Clinical Level of Lesion (n=31)

Patient No.Age (yrs)Highest level of LMN/ UMN weaknessHighest level of wastingHighest level of segmental reflex lossHighest Pyramidal (Reflex) levelHighest sensory level (spino-thalamic)Highest sensory level (posterior column)Clinical level of lesion
140---T6--Above T6
222---C2C5-Above C2
350T6--T6T6T6AboveT6
456C7--C7-T2Above C7
545C2C2-C5Onion-peel sensory loss over faceC8-T1Cervcio-medullary
640C2C2-L1-L1C2
760C7-T1C7-T1C7C5-T4Above C5 Lower T1
863C2C2-C5T4T4C2
949T6-C5C7-T6C5
1036C5--C2Onion-peel sensory loss over faceT4Cervico-medullary
1153C7-C7--Above C7
1230C2C2C5C7-C8-T1C2 Lower level C5
1342C2C2-T6-T4C2
1413T6--C2Onion-peel sensory loss over faceT6Cervico-medullary
1524T6--C2T4T4Above C2
1647C6C6-C2T6T6Above C2 Lower level C6
1718T6-C5T6Onion-peel sensory loss over face-Cervico-medullary
1830C5--C5-T10Above C5
1930T6-C5T6C7-T1-C5
2028C5--C5-T6Above C5
2160---C5-C5Above C5
2216C5--C5-C5Above C5
2330C5--C5-T4Above C5
2455T6--T6T6-Above T6
2525C5--C5T4T4Above C5
2632C5--C5C5-Above C5
2717T6--C2-T6Above C2
2853T6-C5C7L1L1C5 level
2925C5--C2Onion-peel sensory loss over faceT4Cervico-medullary
3055C5C5C5C7-T6C5 level
3160C5C5C5C7--C5 level
Total19-2972083

‘–’Absent deficits/ exact level could not be determined; (“Text in bold” indicates clinical features used for determining highest level of lesion in each of the patient. The last row “Total”gives total number of patients in whom a clinical feature was useful to determine highest clinical level)


Pyramidal signs helped to localize the highest level of lesion in only 12 patients. The level of lesion was above C2 (brisk Trapezius reflex) in four patients, above C5 in eight patients, above C7 in two patients and above T6 in one patient. Two other patients with pyramidal level above T6 also had sensory level at T6. The jaw jerk was normal (just elicited/ absent) in all the 31 patients. Lower motor neuron (LMN) features in the form of muscle weakness and wasting were present in nine patients and segmental reflex loss in eight patients. Together, they helped to localize the highest level of lesion in nine patients.

Sensory system involvement suggested the highest level of lesion in five patients. All of them had onion-peel sensory loss over face. In five other patients, the highest level was indicated by combined involvement of pyramidal and sensory system involvement.

As mentioned previously, the patients were divided into three groups 1) cervico-medullary region (foramen magnum to C1 level), 2) upper cervical region (from C2-C4), 3) lower cervical region (C5-T1).

The group with cervico-medullary region involvement included nine patients. Five patients demonstrated onion-peel sensory loss over face, localizing the lesion to cervico-medulary region (up to C1 level). One of them had downbeat nystagmus and another patient had suboccipital muscle wasting. Other findings in this group of patients included wasting of Trapezius muscle and C5 level reflex loss indicating extension of lesion to upper and lower cervical regions respectively. Four other patients had brisk trapezius reflex localizing the lesion to “above C2 level.” In all these patients, the jaw jerk was normal and there were no other findings indicative of a lesion above foramen magnum. Hence, they were also included in this group. The other findings in these patients comprised of – spino-thalamic sensory level at C5 in one patient, paradoxical respiration along with sensory (spino-thalmaic and posterior column) and reflex level above T6 in one patient, and sensory (posterior column) and, reflex level above T6 in one patient. One other patient had C6 segmental muscle wasting indicative of extension of lesion to lower cervical region.

Four patients had clinical evidence of upper cervical cord lesion (C2-C4 level). Weakness of Trapezius with absent Trapezius reflex in all these four patients and paradoxical respiration with respiratory insufficiency in three patients was the signs which enabled us to localize the lesion to upper cervical region. All four of the patients also had suboccipital muscle wasting. One of the above patients had reflex loss at C5 indicating extension of lesion to lower cervical region. One other patient, included under cervico-medullary region, had weakness and wasting of Trapezius muscle indicating extension of lesion to upper cervical region.

Segmental wasting, weakness, reflex loss served as the most important signs to localize the lesion to the lower cervical level (C5-T1 level). Among the 31 patients, five patients had clinical evidence of lower cervical cord lesion – at C5 level in all the patients. Sensory level, seen in two of the patients was at much lower level (C7-T1 level in one patient and L1 level in another patient). One patient each listed above under cervico-medullary and upper cervical region respectively had C5 segmental reflex loss indicative of extension of the lesions to lower cervical region.

Clinically, 16 patients were considered to have extradural compressive myelopathy evidenced by the presence of neck pain (n=13), local tenderness over the spine (n=5), later involvement of bladder, hemiparetic type of weakness progressing to quadriparesis (n=5) and ‘Elsberg’ pattern of evolution of limb weakness (n=6). Five patients were clinically diagnosed to be having intramedullary lesion based on the combination of ‘dissociated sensory losses’, brisk reflexes in lower limbs with wasting of small muscles of hands and sluggish reflexes in upper limbs. 10 patients were diagnosed as non-compressive myelopathy by history of fever preceding myelopathy, absence of neck pain and a relapsing-remitting course of the illness (n=4).

MRI Abnormalities

With cord signal changes in the MRI being an inclusion criterion, MRI of cervical spine was abnormal in all the 31 patients. Gadolinium enhanced MRI sequences had been performed in all patients. 15 patients were also investigated with MRI brain (postcontrast and FLAIR sequences). MRI brain was normal in all of them. On axial MRI sections, there was no evidence of root compression in any of the patients.

The horizontal as well as vertical extent of the lesions was determined from T2 and Postcontrast images of the cervical cord. Based on the vertebral level at which the abnormalities were seen, the lesions were grouped into three groups: cervico-medullary (CM) (foramen magnum to C1) [Table/Fig-5]; upper cervical (UC) (C2-C4) [Table/Fig-6] and lower cervical (LC) (C5-T1) [Table/Fig-7] regions. The lesions involved single region in 13 patients (CM level – 2, UC level – 4, LC level – 7) and two regions in 17 patients (CM+UC – 2, UC+LC – 15). In one patient, MRI showed the lesion to be involving all three region (CM+UC+LC). The details of the T1 and T2 characteristics of the lesions, their contrast enhancement, vertical and horizontal extent and, plane of the lesions, and probable MRI diagnosis are depicted in [Table/Fig-8].

The sagittal section of the cervical spinal cord MRI (T2 weighted) showed atlanto-axial dislocation with cervico-medullary compression

The sagittal section of the cervical spinal cord MRI (T2 weighted) showed spondylotic cord compression with hyperintense cord signal change at the C3-4 level

The sagittal section of the cervical spinal cord MRI (T2 weighted) shows spondylotic cord compression with hyperintense cord signal change at the C5-6 level

Details of MRI abnormalities (n=31)

Patient No.T1W imagesT2W imagesSwelling of the CordContrast enhancementLevel of lesionHorizontal Extension of lesionPlane of lesionMRI Diagnosis
1IsointenseHyperintense--C4-5CentralEDCSM
2HypointenseHyperintense++C3-5Whole cordIMIntramedullary Neoplasm
3IsointenseHyperintense--C4-5CentralEDCSM
4IsointenseHyperintense--C3-4; C4-5; C5-6CentralEDCSM
5IsointenseHyperintense--Cervico- MedullaryCentralEDAAD with cord compression
6HyperintenseHyperintense-+C3-4Whole cordEDAVM
7IsointenseHyperintense--C2-3; C4-5; C6-7CentralEDCSM
8HypointenseHyperintenseAtrophy+C3-4AnteriorIMIschemic myelopathy
9IsointenseHyperintense--C5-6Rt. HemicordEDCSM
10HypointenseHyperintense--Cervico- MedullaryWhole cordIMDemyelination
11IsointenseHyperintense--C5-6CentralEDCSM
12IsointenseHyperintense--C3-5; C6-7CentralEDCSM
13IsointenseHyperintense--C7-T1CentralEDCSM
14HypointenseHyperintense-+C1-3PosteriorIMDemyelination
15IsointenseHyperintense--C3-4Lt. HemicordEDTraumatic
16IsointenseHyperintense--C3-4CentralEDOPLL
17HypointenseHyperintense++C1-T2CentralIMSyringomyelia
18HypointenseHyperintense--C3-6Whole cordIMDemyelination
19HypointenseHyperintense++C4-6CentralIMSyringomyelia
20HypointenseHyperintense++C4-5Whole cordIMDemyelination
21IsointenseHyperintense--C4-5CentralEDCSM
22HypointenseHyperintense--C4-6Whole cordIMDemyelination
23HypointenseHyperintense-+C3-6Whole cordIMDemyelination
24HypointenseHyperintense++C5-T1CentralIMSyringomyelia
25HypointenseHyperintense-+C6-T1PosteriorIMDemyelination
26HypointenseHyperintense++C4-7Whole cordIMIntramedullary Neoplasm
27HypointenseHyperintense++C3-6Whole cordIMDemyelination
28IsointenseHyperintense--C5-6CentralEDCSM
29HypointenseHyperintense-+C1-2PosteriorIMDemyelination
30IsointenseHyperintense--C4-5CentralEDCSM
31IsointenseHyperintense--C5-6CentralEDCSM

(+: Present; - : Absent; IM- Intramedullary; ED- Extradural; CSM- Cervical spondylotic myelopathy; AAD- Atlanto-axial dislocation; AVM- Arterio-venous malformation; OPLL – Ossified Posterior Longitudinal Ligament)


The various etiologies of cervical myelopathy (n=31) as revealed by MRI of the cervical spine were: cervical spondylotic myelopathy – 13 patients (40.6%), demyelination – nine patients (29%), syringomyelia – three patients (9.6%), intramedullary tumor (astrocytoma in one and ependymoma in one) – two patients (6.4%), vascular – two patients (AVM in one and ischemic myelopathy in one) (6.4%), traumatic ( partial hanging) – one patient (3.2%) and atlantoaxial dislocation – one patient (3.2%).

The different MRI lesions and their common locations in the present study are as follows: a) post-infectious demyelination (n=3) involved the cervico-medullary junction/ upper cervical regions in three patients, b) vascular myelopathy (n=2) was seen in C3-C4 segments in two patients, c) traumatic myelopathy (n=1) was seen to be involving C3– C4 cord segments in one patient, d) intramedullary tumors (n=2) involved C3-5 segments in one patient and C4-7 segments in another patient, e) idiopathic demyelination (n=2) involved C4-5 in both patients f) demyelination of the Multiple sclerosis type (n=4) involved C3-C6 level in three patients and C6-T1 in one patient, g) cervical spondylotic myelopathy (n=12) involved C5-C6 segment in four patients; C4-5 segment in four patients and multiple segments in four patients, and h) syringomyelia (n=3) involved the whole of the cervical cord in one patient and multiple segments in two patients.

Clinical – Radiological Comparison: [Table/Fig-9]

Clinical levels and MRI level (n=31)

Patient No.Highest clinical levelLowest clinical levelMRI level of lesion
1Above T6-C4-5
2Above C2C5C3-5
3AboveT6-C4-5
4Above C7T2C3-4; C4-5; C5-6
5Cervico-medullaryC8-T1Cervico- Medullary
6C2L1C3-4
7Above C5T1C2-3; C4-5; C6-7
8C2T4C3-4
9C5T6C5-6
10Cervico-medullaryT4Cervico- Medullary
11Above C7-C5-6
12C2C5C3-5; C6-7
13C2T6C7-T1
14Cervico-medullaryT6C1-3
15Above C2T6C3-4
16Above C2C6C3-4
17Cervico-medullaryT6C1-T2
18Above C5T10C3-6
19C5T6C4-6
20Above C5T6C4-5
21Above C5-C4-5
22Above C5-C4-6
23Above C5T4C3-6
24Above T6-C5-T1
25Above C5T4C6-T1
26Above C5-C4-7
27Above C2T6C3-6
28C5 levelL1C5-6
29Cervico-medullaryC5C1-2
30C5 levelT6C4-5
31C5 levelC7C5-6

The clinical diagnosis of compressive/ non-compressive myelopathy was concordant with MRI in all the 31 patients. There was moderate concordance between the maximal antero-posterior extent of the lesion and neurological deficits (p-0.05). The transverse extent of cord MRI abnormalities was further explored in relation to the distribution of sensory involvement. When the horizontal extent of cord MRI abnormalities was compared with sensory symptoms (paresthesias) and signs (sensory loss on examination), the latter showed a high degree of correlation (p – 0.05) than the former (p – 0.11).

As compared to pyramidal signs or sensory abnormalities, segmental features – segmental sensory loss, weakness, wasting or ‘reflex’ loss – were most concordant with the MRI level of lesion (p - 0.03). Segmental features form the foundation for clinical localization of the level of lesion.

Among ‘motor’, ‘sensory’ and ‘reflex’ levels, the ‘reflex (DTR)’ levels were most concordant with the MRI level of lesion (p – 0.04).

The MRI region of involvement was concordant with the clinical level of lesion in 10 patients (CM- 2; UC- 5; LC- 7). 12 patients demonstrated moderate concordance (CM- 3; UC- 7; LC- 3). There was no concordance in 6 patients (UC- 4; LC- 4).

Discussion

After the advent of CT scan and MRI, detection of incidental or multi-segmental abnormalities especially related to cervical or lumbar spondylosis is being increasingly recognized. Hence, the need for segment specific abnormalities for pre-operative evaluation as well as for intra-operative monitoring became apparent. In this study, we have prospectively evaluated the diagnostic usefulness of a detailed clinical examination & MRI in patients with confirmed lesions of the cervical cord. Both are complimentary in detection and precise localization of the level of lesion in patients with cervical myelopathy.

All together, clinical localization of level of lesion was done using pyramidal signs. It is worth noting that the pyramidal, sensory and reflex levels were concordant in only 16.1% patients. Hence, the need for careful examination to detect segmental features.

Many earlier studies on cervical myelopathy have included patients of only single pathology like CSM [10], Syringomyelia [11] or intramedullary tumors [12]. We have included patients with various etiologies of cervical myelopathy such as CSM, demyelination, syringomyelia, tumor, trauma, vascular lesions and Atlanto-Axial Dislocation. This was basically done to ensure inclusion of patients with lesions at different levels of the cervical cord.

MRI of the cervical spine showed features of CSM in 14 patients. This reflects up on cervical spondylosis being a common cause of cervical myelopathy as in other parts of the world. Spondylotic myelopathy commonly involved C5-6 and C4-5 segments. Usually, spondylotic myelopathy involves C4-5, C5-6 and C6-7 segments because disc degeneration is greatest in the cervical spine at these levels [5]. The different levels of involvement in the present study may indicate selection bias by inclusion of in-patients with severe myelopathy admitted for cervical spine surgery.

The clinical diagnosis of compressive/ non-compressive myelopathy was concordant with MRI in all the 31 patients. It indicates reliability of clinical features for making a diagnosis of compressive or non-compressive myelopathy. However, the good concordance may also have been influenced by inclusion of patients in the study after MRI of the cervical spine.

In 26/31 patients, transverse extent of the lesion in MRI demonstrated good concordance with the presence of unilateral or bilateral sensory abnormalities. However, there was only a moderate concordance between clinical features and antero-posterior extent of the lesion in MRI. The less extensive clinical involvement as compared to the MRI extent of the lesion may be due to greater sensitivity of MRI for demonstrating the presence and extent of lesions. For example, it is well documented that imaging studies show many clinically silent lesions in patients with stroke, demyelinating process and many other neurological disorders [4]. On the contrary, among the four patients with MRI lesion apparently involving only the posterior cord, three patients had both sensory as well as motor abnormalities. This indicates that lesions to explain the neurological deficits are not always evident in the MRI. For most patients presenting with a spinal cord syndrome MRI has become the key investigation in establishing the diagnosis. However, myelopathy with normal spinal imaging remains a common clinical conundrum [13].

Conclusion

Segmental features form the foundation for clinical localization of the level of lesion. Though the clinical level of lesion and MRI level of lesion were discordant in 14 patients, clinical evaluation may still provide useful information and this can be confirmed by correlation with somatosensory evoked potential studies.

References

[1]Adams RD, Victor M, Priciples of neurology 1989 4th edNew YorkMcGraw-Hill:440  [Google Scholar]

[2]Katz JD, Ropper AH, Progressive necrotic myelopathy: clinical course in 9 patients Arch Neurol 2000 57(3):355-61.  [Google Scholar]

[3]Mehalic TF, Pezzuti RT, Applebaum BI, Magnetic resonance imaging and cervical spondylotic myelopathy Neurosurgery 1990 26:217-27.  [Google Scholar]

[4]Lublin FD, Miller AE, Multiple sclerosis and other inflammatory demyelinating diseases of the CNS. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J (eds) Neurology in clinical practice 2008 5th edn:1583-1613.  [Google Scholar]

[5]Carette S, Fehlings MG, Cervical radiculopathy N Engl J Med 2005 353:392-9.  [Google Scholar]

[6]Singhal BS, Multiple Sclerosis and related demyelinating disorders in the Indian context Neurol India 1987 37:1-12.  [Google Scholar]

[7]Gowrie-Devi M, Nagaraja D, Multiple sclerosis in South India. In: Kuroiwa Y, Kurland LT (eds) Multiple Sclerosis East and West 1982 JapanKyushu University Press:135-47.  [Google Scholar]

[8]Woolsey RM YR, The clinical diagnosis of disorders of the spinal cord Neurol Clin 1991 9:573-81.  [Google Scholar]

[9]Adams KK, Jackson CE, Rauch RA, Cervical myelopathy with false localizing sensory levels Arch Neurol 1996 53:1155-58.  [Google Scholar]

[10]Restuccia D, Lazzaro Di, Valeriani M, Tonali P, Mauguiere F, Somatosensory evoked potentials after multisegmental upper limb stimulation in diagnosis of cervical spondylotic myelopathy J Neurol Neurosurg Psychiatry 1994 57:301-08.  [Google Scholar]

[11]Restuccia D, Mauguiere F, The contribution of median nerve SEPs in the functional assessment of the cervical spinal cord syringomyelia Brain 1991 114:361-79.  [Google Scholar]

[12]Ibanez V, Fischer G, Mauguiere F, Dorsal horn and dorsal column dusfunction in intramedullary cervical cord tumors Brain 1992 115:1209-34.  [Google Scholar]

[13]Wong SH, Boggild M, Enevoldson TP, Fletcher NA, Myelopathy but normal MRI: where next? Practical Neurology 2008 8:90-102.  [Google Scholar]